secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apimeds Pharmaceuticals US, Inc. (APUS)
CIK:        0001894525
Form:       8-K
Filed at:   2026-03-16T23:59:59+00:00
Accession:  0001213900-26-028332
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Apimeds Pharmaceuticals to effect 1-for-10 reverse stock split on March 26, 2026
--------------------------------------------------------------------------------

- Stockholders approved 1-for-10 reverse stock split via written consent in December 2025.
- Reverse split effective 12:01 a.m. ET March 26, 2026; trading begins on split-adjusted basis same day.
- Every 10 pre-split shares convert to 1 share; new CUSIP 03771D201.
- Company expects to file charter amendment with Delaware Secretary of State around March 25.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894525/000121390026028332/0001213900-26-028332-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894525/000121390026028332/ea0281820-8k_apimeds.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-028332

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer